ORGO
Organogenesis Holdings, Inc. Class A · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website organogenesis.com
- Employees(FY) 1030
- ISIN US68621F1021
Performance
+20.18%
1W
-4.2%
1M
-21.26%
3M
+8.3%
6M
-33.01%
YTD
-13.84%
1Y
Profile
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly, a antimicrobial barrier that enables conformability and fluid drainage. Its products also include FortiShield, a biosynthetic wound matrix for use as a temporary wound covering; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly AM, PuraPly XT, and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales representives and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Investment Analysis Report: ORGO
Overview:
ORGO is a company operating in the Health Technology sector, specifically in the Medical Specialties industry. The company has shown consistent growth in its financial metrics over the past three years, as evidenced by its balance sheet, income statement, and cash flow statement data.
Balance Sheets Ana...
Technical Analysis of ORGO 2024-05-10
Overview:
In analyzing the technical indicators for ORGO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating, indicating ...
Recent News & Updates
- 2024-05-10 03:09
- 2024-05-10 00:07
- 2024-05-09 23:49
Q1 2024 Organogenesis Holdings Inc Earnings Call(Yahoo Finance)
- 2024-05-09 08:45
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript(Yahoo Finance)
- 2024-05-09 05:41
Organogenesis: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-09 04:05
- 2024-05-01 19:00
- 2024-04-15 19:30
- 2024-04-02 19:30
- 2024-03-01 19:39
- 2024-03-01 19:39
- 2024-03-01 05:29
Why Organogenesis Holding Stock Plummeted by 18% Today(Yahoo Finance)
- 2024-02-29 17:45
- 2024-02-29 16:50
Organogenesis: Q4 Earnings Snapshot(Associated Press Finance)
- 2024-02-29 16:38
- 2024-02-29 16:05
- 2024-02-29 03:05
- 2024-02-12 07:30
- 2024-02-11 18:30
- 2024-02-08 16:05
- 2024-02-08 03:05
- 2024-01-15 12:00
- 2024-01-14 07:11
- 2024-01-12 06:29
Daily – Vickers Top Buyers & Sellers for 01/12/2024(Argus Research)
- 2024-01-05 10:00
- 2024-01-05 06:39
- 2023-12-28 12:00
- 2023-12-18 16:08
3 Biotech Stock Buys to Boost and Supercharge Portfolios(entrepreneur)
- 2023-12-18 05:24
- 2023-12-07 07:48
Page 1 of 5
previousnext